LAL-D: much more than a rare disease

LAL-D: much more than a rare disease

14 May, 2026 | blog

A new publication in Hepatology International provides important evidence about the role of lysosomal acid lipase (LAL) in liver disease progression. The study shows that lower LAL activity is associated with: 👉 Increased liver inflammation 👉 Greater fibrosis...
“Accede Público Digital” Project

“Accede Público Digital” Project

14 May, 2026 | blog

The National Federation of Liver Patients and Transplant Recipients (FNETH), part of COCEMFE, is running in 2026 the project “Accede Público Digital” to support people with disabilities—especially physical and/or organic disabilities—who want to explore or prepare for...
LAL‑D Study – Phase 3

LAL‑D Study – Phase 3

2 Apr, 2026 | blog

LAL‑D Study – Phase 3   the University of Rochester (USA) is currently conducting Phase 3 of its research project on Lysosomal Acid Lipase Deficiency (LAL‑D). Our organization is not conducting this study, but we would like to help share this opportunity and...
Genetic liver diseases: rare, but clinically highly relevant

Genetic liver diseases: rare, but clinically highly relevant

31 Mar, 2026 | blog

Genetic liver diseases: rare, but clinically highly relevant This article highlights that genetic liver diseases, while individually uncommon, represent a significant and often underdiagnosed cause of chronic liver disease in adults. Detection is particularly...